Non-Small Cell Lung Cancer (NSCLC) Treatment in Turkey
- Top Accredited Hospitals
- Global Medical Standards
- Cutting-Edge Technology
- Proven Treatment Options
- High Success Rate
- Trusted by Millions
What is Non-Small Cell Lung Cancer (NSCLC)?
About 85% of all instances of lung cancer are non-small cell lung cancer (NSCLC), making it the most common kind of the disease. It happens when aberrant cells proliferate in the lungs and cause tumors to grow. Compared to small cell lung cancer (SCLC), non-small cell lung cancer (NSCLC) is typically less aggressive and grows and spreads more slowly.
Type of Non-Small Cell Lung Cancer (NSCLC)
There are many types of NSCLC, including-
- Adenocarcinoma: It typically develops in the outer parts of the lungs and is the most common type of lung cancer.
- Squamous Cell Carcinoma: Usually starts in the central part of the lungs and is often associated with a smoking history.
- Large Cell Carcinoma: It can develop in any part of the lungs and is prone to grow and spread quickly
What is the Importance of Timely Treatment?
Timely treatment of Non-Small Cell Lung Cancer (NSCLC) is essential for several reasons:
- Improved Prognosis: With surgery or localised radiotherapy, early-stage NSCLC can frequently be successfully treated, increasing the chance of long-term survival. Early detection increases the likelihood of the cancer being successfully treated and having a favorable outcome.
- Prevents Spread: If treatment is not received, non-small cell lung cancer (NSCLC) can spread (metastasise) to other body areas, including the brain, liver, and bones, making treatment more difficult and decreasing the likelihood of survival.
- Treatment Effectiveness: More treatment options, such as surgical resection or targeted medicines, are available with an early diagnosis; these alternatives may become less effective as the cancer progresses.
- Minimizes Complications: The likelihood of consequences, including lung collapse, breathing problems, or fluid accumulation, which might occur as the cancer worsens, is decreased with prompt treatment.
- Better Quality of Life: Early cancer detection can improve symptom management and help people live better while undergoing treatment and recuperating.
What are the Common Symptoms of Non-Small Cell Lung Cancer (NSCLC)?
Respiratory Symptoms
- Persistent Cough
- Shortness of Breath
- Coughing Up Blood
- Wheezing
Chest Symptoms
- Chest Pain
- Hoarseness
General Symptoms
- Loss of Appetite
- Unexplained Weight Loss
- Fatigue
- Frequent Infections such as bronchitis or pneumonia
Causes and risk factors of Non-Small Cell Lung Cancer (NSCLC)?
Causes
- Genetic alterations that lead to changes in the DNA of lung cells cause the uncontrolled expression of genes and ultimately cause cancer.
- Prolonged exposure to certain chemicals and toxins may increase the risk factor of developing NSCLC cancer.
Risk Factors
- Smoking tobacco
- Environmental exposures like radon, Asbestos and air pollution, exposure of some workplace chemicals like formaldehyde, arsenic, and benzene.
- Family history of lung cancer
- Older age above 60-80 years
- Having respiratory conditions like pulmonary fibrosis.
- Previous radiation therapy for breast and chest
Connect with our advisor for a PRIORITY response
Latest Research and Technologies in the Treatment of Non-Small Cell Lung Cancer (NSCLC) in Turkey
Through the use of immunotherapies, targeted medicines, and innovative research, Turkey has achieved notable progress in the treatment of non-small cell lung cancer (NSCLC). Gene mutations are treated with protein inhibitors (TKIs), and other NSCLC instances benefit from immune checkpoint medications. Recent research has been devoted to combining immunotherapy with targeted treatments to improve efficacy and reduce resistance.
Non-Small Cell Lung Cancer (NSCLC) Prevention Tips
There are a few things you can do to lower your risk of developing Non-Small Cell Lung Cancer (NSCLC), particularly of the bladder, even if it is not always preventable:
- Avoid smoking
- Avoid second hand smoke
- Limit exposure to carcinogens like radon, asbestos, and arsenic.
- Maintain a healthy lifestyle by improving lifestyle modifications such as eating a well-balanced diet, exercising regularly to improve lung function, and maintaining a sleep-wake cycle to support the immune system.
- Early genetic counseling shall be considered; screening can help identify genetic mutations and guide preventive measures.
- Reduce exposure to air pollution
- Protect Yourself from Occupational Hazards
Treatment options for Non-Small Cell Lung Cancer (NSCLC)
Treatment options for NSCLC differ based on the type and stage of the disease and the patient's overall health. The following are a few current treatments:
Lobectomy: Elimination of a lung lobe. The most popular procedure for NSCLC in its early stages is this one.
Pneumonectomy: Removal of a lung in its whole. If the cancer is in an area of the lung where the entire organ needs to be removed, this procedure might be carried out.
Wedge Resection: This removes a little lung section with the tumor.
Segmentectomy: This is the Removal of a more prominent lung segment but not the entire lobe. Usually, this is applied to individuals with lung impairment or early-stage cancer.
Radiation Therapy: Treatments using high-energy rays to target cancer cells and reduce tumour size are known as radiation therapy. It may be used in combination with chemotherapy for Non-Small Cell Lung Cancer (NSCLC).
Targeted Therapy : Medication designed for particular forms of lung cancer is used in this treatment. Targeted therapy can locate and target specific cancer cells without endangering healthy cells.
Cost Start From USD 7500 - USD 12000Explore Options
Immunotherapy : This is typically advised for late-stage lung cancer, notably Stage IV NSCLC, as it triggers your body's immune system to target and eliminate cancer cells.
Cost Start From USD 7420 - USD 42500Explore Options
Chemotherapy : It uses medications that target lung cancer. It is among the most widely used therapies for NSCLC. Chemotherapy may be prescribed by your oncologist alone or in conjunction with other treatments.
Cost Start From USD 7420 - USD 30000Explore Options
Clinical Evaluation
- Medical History and Physical Examination: Healthcare professionals assemble detailed information about symptoms, medical history and risk factors afterlooking at NSCLC symptoms.
Imaging Studies
- CT Scan
- Chest X-Ray
- MRI
- PET Scan
Biopsy
- Bronchoscopy
- Needle Biopsy
- Surgical Biopsy
Laboratory Tests
- Blood Tests
- Sputum Cytology
- Thoracentesis
MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive rehabilitation services to support patients through Teleconsulations and online therapy sessions.
Lifestyle changes and modification
While lifestyle modifications like stress reduction, yoga, and meditation improve general well-being, dietary changes involving high-fiber meals, lean meats, and supplements boost nutrition. Long-term health is further enhanced by abstaining from alcohol and eating a balanced diet.
Speech and Swallowing Therapy
Patients with NSCLC may have trouble speaking or swallowing if the disease affects the mouth, throat, or digestive system. Speech therapists can help patients regain clarity in their speech and enhance their swallowing function.
Monitoring and follow-up
Schedule regular follow-up appointments with the oncologist to address complications, monitor recovery, and detect any signs of recurrence.
Depending on the circumstances, your doctor might recommend medication to help manage your symptoms and complement the course of treatment.
Instantly Connect with our Specialists
Hospitals for Non-Small Cell Lung Cancer (NSCLC) in Turkey
Medicana Camlica Hospital
Istanbul, Turkey
Medicana Camlica Hospital located in Istanbul, Turkey is accredited by JCI. Also listed below are some of the most prominent infrastructural details:
- 150 bedded Hospital
- Specialty-based clinics
- Fully-equipped patient rooms
Hisar Intercontinental Hospital
Istanbul, Turkey
Architecture of the Hospital designed as per the comfort of patients-
- Consisting of 8 floors, 212 bed capacity
- 75m2 suite rooms
- 35 thousand m2 closed area
- 7 operating rooms
- 53 polyclinics
- 54 Departments
- Hotel-like patient rooms
- Intensive care units consisting of 33 beds
- Hyperbaric Oxygen Center inside the hospital
- PYXIS computerized medicine system working with fingerprint
- Social waiting areas
- Indoor and Outdoor Cafeterias & Restaurants
Acibadem Kadikoy Hospital
Istanbul, Turkey
Acibadem Kadikoy Hospital located in Istanbul, Turkey is accredited by JCI. Also listed below are some of the most prominent infrastructural details:
- The number of beds in the hospital are 138 and Intensive Care beds are 23.
- There are as many as 6.500 access points for a building control system.
- There are 10 Operating theatres and more than 500 employees.
- There are specific healthcare facilities in Acibadem Kadikoy Hospital, Istanbul, Turkey which have been established per integrated healthcare outreach such as Breast Health Center, Check-up Center, and Diabetes Clinic etc.
- The hospital has the very best of Medical Technologies such as Flast CT, da Vinci robot, Magnetom Area MRI, Greenlight, Ortophos XG 3D and Full Body MRI, 4-Dimensional Breast Ultrasound, 3-Dimensional Tomosynthesis Digital Mammography.
Our Services to better your experience
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Why Choose Turkey for Treatment of Non-Small Cell Lung Cancer (NSCLC)?
- World-Class Healthcare Facilities: Turkey's modern hospitals and medical facilities have the newest technologies to spot and treat rare cancers like Non-Small Cell Lung Cancer (NSCLC).
- Affordable Treatment: Turkey offers Non-Small Cell Lung Cancer (NSCLC) treatment at a substantially lower cost than many Western nations without sacrificing care quality. Patients who receive top-notch care should anticipate significant cost reductions on everything from surgeries to cutting-edge treatments like radiation, surgeries and chemotherapy. Turkey is a well-liked medical tourism destination because of this cost advantage.
- Comprehensive Treatment Options: Turkeya provides a holistic approach to treating Non-Small Cell Lung Cancer (NSCLC), including radiation therapy, Chemotherapy and surgical resection. New developments like gene treatments and tailored therapy are becoming more widely available to treat NSCLC better.
- Advanced Diagnostic Tools: Advanced diagnostic treatments like Lobectomy, Pneumonectomy, Wedge Resection, and Segmentectomyare available in Turkish hospitals to ensure precise diagnosis and treatment planning.
- Post-Treatment and Rehabilitation Care: Patients with NSCLC can receive complete rehabilitation programs in Turkey that include mental support, dietary counselling, and physical therapy. Patients who receive ongoing care and follow-up services are guaranteed access to the emotional support and monitoring they require while recovering.
Frequently Asked Questions
In Turkey, recovery times following therapy for non-small cell lung cancer (NSCLC) vary depending on the type of treatment, the features of the tumor, and the patient's health. Recovery from other therapies, like as chemotherapy or radiation, can take anything from a few weeks to several months, whereas recovery from surgery may take between 6 to 12 weeks.
In Turkey, it is customary practice to get a second opinion. A lot of hospitals and oncologists are willing to assess cases and offer second opinions on treatment strategies. One can:
- Forward pathology reports, imaging, and medical records to the hospital for evaluation.
- Set up a consultation with the specialist you choose, either in person or via teleconference.
- For NSCLC, major hospitals frequently have a team of experts who may offer a second opinion on the optimal treatment plan.
Yes, MediGence offers a wide range of assistance to patients from other countries seeking treatment for non-small cell lung cancer. The majority of large hospitals offer specialised departments for international patients that help with accommodations, airport transfers, visa arrangements, and language translation. To ensure that overseas patients have a seamless and hassle-free experience throughout their treatment journey, these departments also assist with financial information, appointment scheduling, and post-treatment care.
To minimise side effects and keep an eye out for recurrence, post-treatment care for non-small cell lung cancer (NSCLC) in Turkey involves routine follow-ups with oncology specialists. Individualised rehabilitation plans and lifestyle counseling are provided to patients in order to improve their general health and speed of recovery.
Yes, even after a successful course of treatment, non-small cell lung cancer (NSCLC) might return. The type of treatment received, the patient's response to the treatment, and the stage of the cancer at diagnosis all affect the chance of recurrence.
In Turkey, the prognosis for individuals with non-small cell lung cancer (NSCLC) varies according to the cancer stage at diagnosis, general health, and response to treatment. Early identification and sophisticated treatment options available in Turkey can enhance survival chances.
About 41,000 new instances of lung cancer were reported in 2020, making it the most common cancer in Turkey. About 80% of these cases are non-small cell lung cancer (NSCLC), which makes it a prevalent cancer type in the nation.
Turkey is a cost-effective choice for those seeking treatment because it provides top-notch medical care at affordable costs compared to several Western nations.
Yes, Turkey's healthcare system accepts patients from abroad and provides excellent NSCLS treatments at many clinics and hospitals.
Yes, many Turkish hospitals offer in-person and online consultations to foreign patients who want a second opinion.